MedPath

Intra- and postoperative clinical evaluation for hysteroscopic surgery with the TRUCLEAR system (Prospective randomized single-blind parallel group comparison study)

Phase 3
Conditions
Submucous myoma Endometrial polyp
Registration Number
JPRN-UMIN000019649
Lead Sponsor
Teikyo University
Brief Summary

The polyps were completely removed, and no adverse events were observed in all 67 patients. The average operating time (8.3 min vs. 12.0 min, P = 0.014), insertion time (5.0 min vs. 9.0 min, P < 0.001), and number of insertions (1.0 vs. 8.2, P < 0.001) were significantly lower in the morcellation arm than in the electrosurgical resection arm.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with submucous myoma larger than 2 cm in diameter 2. Patients with FIGO type 2 submucous myoma 3. Patients who have received hysteroscopic myomectomy or polypectomy before 4. Patients with uterus bipartitus 5. Patients with intrauterine adhesion 6. Patients with endometrial carcinoma or suspected endometrial carcinoma 7. Patients who are judged ineligible by the principal investigator or sub-investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Operating time
Secondary Outcome Measures
NameTimeMethod
1. Removal success 2. Fluid deficit 3. Convenience with technique 4. Insertion time during surgery 5. Visibility of Operation Field 6. Recurrence of chief complaint 7. Adverse event 8. Pain, expectation, and satisfaction evaluated by patient
© Copyright 2025. All Rights Reserved by MedPath